A detailed history of Beck Mack & Oliver LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 15,120 shares of EW stock, worth $990,057. This represents 0.03% of its overall portfolio holdings.

Number of Shares
15,120
Previous 15,120 -0.0%
Holding current value
$990,057
Previous $1.44 Million 3.32%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

BUY
$57.54 - $76.95 $580,003 - $775,656
10,080 Added 200.0%
15,120 $1.05 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $22,296 - $25,764
-400 Reduced 7.35%
5,040 $931,000
Q1 2019

May 02, 2019

BUY
$47.89 - $64.05 $19,156 - $25,620
400 Added 7.94%
5,440 $1.04 Million
Q3 2017

Oct 27, 2017

BUY
$36.29 - $38.83 $182,901 - $195,703
5,040
5,040 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.